none7noThis study investigated Kit receptor dysregulations (cytoplasmic immunohistochemical expression and/or c-KIT mutations) in cats affected with splenic mast cell tumours. Twenty-two cats were included. Median survival time was 780 days (range: 1-1219). An exclusive splenic involvement was significantly (P = 0.042) associated with longer survival (807 versus 120 days). Eighteen tumours (85.7%) showed Kit cytoplasmic expression (Kit pattern 2, 3). Mutation analysis was successful in 20 cases. Fourteen missense mutations were detected in 13 out of 20 tumours (65%). Eleven (78.6%) were located in exon 8, and three (21.6%) in exon 9. No mutations were detected in exons 11 and 17. Seven mutations corresponded to the same internal tandem dupl...
none6mixedSabattini S; Guadagni-Frizzon M; Turba ME; Gentilini F; Capitani O; Bettini GSabattini S; ...
AbstractThe c-KIT proto-oncogene has been implicated in the pathogenesis of several neoplastic disea...
Abstract Background Mutations in the c-KIT proto-oncogene have been implicated in the progression of...
This study investigated Ki t receptor dysregulations (cytoplasmic immunohistochemical expression an...
none6noFeline cutaneous mast cell tumors (FeCMCTs) are characterized by variable biological behavior...
Introduction Feline cutaneous mast cell tumours (cMCTs) are characterized by a variable biologic beh...
Feline cutaneous mast cell tumors (FeCMCTs) are characterized by variable biological behavior. Devel...
none6Introduction: Feline mast cell tumours (FeMCTs), overall Accounting for 1e9% of feline neoplasm...
none9siObjectives: Feline intestinal mast cell tumours (FIMCTs) are rare and reportedly characterise...
Abstract. Twenty-seven feline cutaneous mast cell tumors (MCTs) were selected for this retrospective...
The proto-oncogene c-KIT encodes a growth factor receptor, KIT, with ligand-dependent tyrosine kinas...
Mast cell tumour (MCT) is the most common skin neoplasm in dogs. Accurately predicting MCT behaviour...
AbstractImatinib inhibits the activity of several tyrosine kinases, including BCR-ABL, KIT and plate...
In the current study, we examined the types and frequency of KIT mutations in mast cell tumors from ...
Introduction: Canine cutaneous mast cell tumour (MCT) is one of the most common neoplasm in dogs. ...
none6mixedSabattini S; Guadagni-Frizzon M; Turba ME; Gentilini F; Capitani O; Bettini GSabattini S; ...
AbstractThe c-KIT proto-oncogene has been implicated in the pathogenesis of several neoplastic disea...
Abstract Background Mutations in the c-KIT proto-oncogene have been implicated in the progression of...
This study investigated Ki t receptor dysregulations (cytoplasmic immunohistochemical expression an...
none6noFeline cutaneous mast cell tumors (FeCMCTs) are characterized by variable biological behavior...
Introduction Feline cutaneous mast cell tumours (cMCTs) are characterized by a variable biologic beh...
Feline cutaneous mast cell tumors (FeCMCTs) are characterized by variable biological behavior. Devel...
none6Introduction: Feline mast cell tumours (FeMCTs), overall Accounting for 1e9% of feline neoplasm...
none9siObjectives: Feline intestinal mast cell tumours (FIMCTs) are rare and reportedly characterise...
Abstract. Twenty-seven feline cutaneous mast cell tumors (MCTs) were selected for this retrospective...
The proto-oncogene c-KIT encodes a growth factor receptor, KIT, with ligand-dependent tyrosine kinas...
Mast cell tumour (MCT) is the most common skin neoplasm in dogs. Accurately predicting MCT behaviour...
AbstractImatinib inhibits the activity of several tyrosine kinases, including BCR-ABL, KIT and plate...
In the current study, we examined the types and frequency of KIT mutations in mast cell tumors from ...
Introduction: Canine cutaneous mast cell tumour (MCT) is one of the most common neoplasm in dogs. ...
none6mixedSabattini S; Guadagni-Frizzon M; Turba ME; Gentilini F; Capitani O; Bettini GSabattini S; ...
AbstractThe c-KIT proto-oncogene has been implicated in the pathogenesis of several neoplastic disea...
Abstract Background Mutations in the c-KIT proto-oncogene have been implicated in the progression of...